Compare OTEX & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OTEX | NOVT |
|---|---|---|
| Founded | 1991 | 1968 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Industrial Machinery/Components |
| Sector | Technology | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.0B |
| IPO Year | 1998 | 1999 |
| Metric | OTEX | NOVT |
|---|---|---|
| Price | $24.95 | $145.55 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 3 |
| Target Price | $27.95 | ★ $194.50 |
| AVG Volume (30 Days) | ★ 988.9K | 366.7K |
| Earning Date | 11-05-2026 | 11-02-2026 |
| Dividend Yield | ★ 4.63% | N/A |
| EPS Growth | ★ 56.36 | N/A |
| EPS | ★ 2.58 | 0.82 |
| Revenue | ★ $2,815,241,000.00 | $521,290,000.00 |
| Revenue This Year | N/A | $15.57 |
| Revenue Next Year | $1.67 | $15.87 |
| P/E Ratio | ★ $9.37 | $176.40 |
| Revenue Growth | 22.88 | ★ 35.49 |
| 52 Week Low | $19.78 | $98.27 |
| 52 Week High | $39.90 | $176.38 |
| Indicator | OTEX | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 67.98 | 53.74 |
| Support Level | $21.59 | $141.72 |
| Resistance Level | $25.57 | $151.41 |
| Average True Range (ATR) | 0.67 | 5.40 |
| MACD | 0.30 | 0.51 |
| Stochastic Oscillator | 95.18 | 67.94 |
Open Text Corp provides data management for enterprise AI, offering a secure data foundation and trusted context for credible AI outcomes across private, public, and sovereign cloud, managed cloud services, API, and on-premises environments. The Company also provides cybersecurity solutions to protect sensitive data, applications and systems across complex hybrid environments, including identity and access management, threat detection and response, data protection and application security. It serves private, public, and regulated sectors, including retail, financial services, government, manufacturing, healthcare, energy, and logistics, with clients. Geographically, it derives maximum revenue from the Americas.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.